Moneycontrol
HomeNewsBusinessCompaniesRP-Sanjiv Goenka, Bain Capital, Dorf Ketal in race to acquire Aquapharm
Trending Topics

RP-Sanjiv Goenka, Bain Capital, Dorf Ketal in race to acquire Aquapharm

Pune-based Aquapharm produces water treatment chemicals. The promoters, the Mangwani family, will likely sell their entire stake, a report has said

July 27, 2023 / 14:06 IST
Story continues below Advertisement
RP-Sanjiv Goenka, Bain Capital, Dorf Ketal are in race to buy Aquapharm.

Kolkata-headquartered RP-Sanjiv Goenka Group, American investment firm Bain Capital and Indian specialty chemical maker Dorf Ketal are reportedly leading the race to acquire Aquapharm Chemicals at a valuation exceeding Rs 4,500 crore.

The Pune-based company makes water treatment chemicals. The promoters, the Mangwani family, would likely sell their entire stake, the Economic Times reported sources as saying.

Story continues below Advertisement

Moneycontrol could not independently verify the development that comes at a time when global buyers are looking to diversify sourcing beyond China, with investors increasingly interested in the Indian chemicals sector.

Aquapharm has picked Stifel Financial Corp as the banker for the transaction.